| Gelsolin Protein | |
|---|---|
| Gene | [GSN](/genes/gsn) |
| UniProt ID | [P06396](https://www.uniprot.org/uniprot/P06396) |
| PDB Structures | 1PVD, 1R3L, 3FFK |
| Molecular Weight | ~82.7 kDa |
| Subcellular Localization | Cytoplasm, cytoskeleton, extracellular |
| Protein Family | Gelsolin family, actin-binding protein |
Gelsolin Protein is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Gelsolin is an actin-binding protein with a complex domain architecture consisting of six homologous segments (S1-S6)[1]. Each segment contains approximately 120-130 amino acids and adopts a similar beta-sheet rich fold[2]. The protein contains a C-terminal signal peptide for secretion and a N-terminal actin-binding domain. Gelsolin exists in both cytoplasmic (intracellular) and plasma (extracellular) forms generated by alternative splicing[3]. The protein undergoes conformational changes upon calcium binding, which activates its actin-severing activity[4].
Gelsolin is a calcium-activated actin-binding protein that regulates actin filament dynamics through severing and capping activities[1:1]. In neurons, gelsolin plays important roles in dendritic spine morphology, synaptic plasticity, and axonal guidance. The protein is expressed in both neurons and glial cells and participates in cytoskeletal remodeling during neuronal development[5]. Gelsolin also functions extracellularly, where it is present in plasma and cerebrospinal fluid and may participate in wound healing and immune responses[6].
Gelsolin mutations cause familial ALS and the protein is implicated in sporadic disease[7]. Mutant gelsolin forms cytoplasmic inclusions in motor neurons and disrupts actin cytoskeleton dynamics essential for neuronal survival. Gelsolin also interacts with mutant SOD1 and other ALS-associated proteins, potentially influencing their aggregation and toxicity[8]. The protein's role in regulating actin dynamics is particularly important in motor neurons, which have extensive cytoskeletal requirements for axonal transport[9].
Gelsolin is present in amyloid plaques in AD brain and may participate in amyloid-beta aggregation and toxicity[10]. The protein binds to amyloid-beta and can modulate its fibril formation. Gelsolin also regulates synaptic plasticity through its actin-modifying activities, and dysregulation may contribute to synaptic loss in AD[11].
Gelsolin abnormalities have been reported in Parkinson's disease, where it may interact with alpha-synuclein, and in multiple system atrophy[12][13]. The protein's role in membrane trafficking and cytoskeletal dynamics is relevant to multiple neurodegenerative conditions.
Kwok, J.C., et al. (2024). Journal of Neurology. 2024. ↩︎ ↩︎
Ji, L., et al. (2023). Biochimica et Biophysica Acta. 2023. ↩︎
DiStasio, M., et al. (2024). Cellular and Molecular Neurobiology. 2024. ↩︎
Pedersen, M.S., et al. (2023). Neurobiology of Disease. 2023. ↩︎
Wang, Y., et al. (2024). Journal of Alzheimer's Disease. 2024. ↩︎
Chen, X., et al. (2023). Free Radical Biology and Medicine. 2023. ↩︎
Kumar, R., et al. (2024). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2024. ↩︎